E1231 is a SIRT1-activating small molecule that upregulates ABCA1 expression. It demonstrates anti-atherosclerotic effects in experimental models, reducing plasma cholesterol and triglyceride levels, making it a valuable research tool for cardiovascular and metabolic disease studies.